Multimodal Pain Treatment for Breast Cancer Surgery - a Prospective Cohort Study

CompletedOBSERVATIONAL
Enrollment

236

Participants

Timeline

Start Date

April 19, 2021

Primary Completion Date

August 4, 2022

Study Completion Date

August 18, 2022

Conditions
Breast Cancer FemalePostoperative PainPostoperative Nausea and Vomiting
Interventions
OTHER

Standardised multimodal pain treatment regimen

"Preoperatively:~* Paracetamol 1000 mg p.o.~* Celecoxib 400 mg p.o.~* Dexamethasone 12 mg p.o.~Perioperatively:~* Ondansetron 4 mg IV~* Bupivacaine 2.5 mg/mL, 20 mL LIA~* Oxycodone 0.15 mg/kg IV (Oxycodone 0.25 mg/kg for ALND)~Postoperatively:~* Paracetamol 1000 mg p.o. every 6h PRN~* Ibuprofen 400 mg p.o. every 6h (day 1-5) PRN~* Oxycodone 5 mg IV or 10 mg p.o. PRN~* Ondansetron 4 mg IV or p.o. PRN"

Trial Locations (1)

4000

Zealand University Hospital, Department of Anaesthesiology, Roskilde

All Listed Sponsors
lead

Zealand University Hospital

OTHER